Recently awarded the i-Lab 2018 competition organised by the French Ministry of Higher Education and Research, Predisurge is continuing its clinical studies and expanding: securing funding, bringing on new team members, and developing commercialisation projects. Selected for the final of the Bercy-IMT competition, it will take part in the next CES in Las Vegas in January 2019.
David Perrin, head of the start-up Predisurge, is working on the design of software for a process to simulate and prepare surgical procedures, providing support for preoperative planning in endovascular surgery.
This year, the team was able to expand thanks to securing public and private funding. It now has six full-time staff and is expected to reach around ten team members at the beginning of next year.
A European multicentre clinical study, conducted by CHU Saint-Étienne, has been launched to assess the young company’s technology. The first results, with more than a third of the study completed, are very promising.
“We are therefore considering commercialising the simulations in the coming months.”
Founded in 2015, Predisurge offers hospital practitioners a digital simulator which, using each patient’s preoperative imaging data, provides a predictive and personalised preview of stent-graft placement in patients.
David Perrin has just taken part in the final of the Bercy-IMT competition “to accelerate the ecosystem’s entrepreneurial gems within IMT”; he has been invited to take part in CES Las Vegas from 8 to 11 January 2019.
The start-up’s activities have also been recognised by the media:
- “Your digital twin can already undergo surgery. And one day it will take medication”, ©Le nouvel observateur, September 2018
- “Focus on the Centre for Biomedical and Healthcare Engineering and scientific work on medical technology challenges”, ©France Bleu Loire, October 2018
- “PrediSurge, the start-up that wants to bring cardiovascular surgery into the era of digital simulation“, ©TICSante.com
- Coming soon on France Télévisions: a Télématin report produced on 21 November on the Santé Innovations Campus at the Centre for Biomedical and Healthcare Engineering.
